Stock price crashing!

[anonymous]

Our stock price is crashing because there is no way we can sell enough of our BS drugs to pay off our huge debt! The Wall Steet guys listened to our earnings call today and could see right away that prescriptions are not growing fast enough to keep the company alive. Just a matter of time before we are all looking for new jobs.

 

[anonymous]

Signing bad managed care contracts just to gain access at all costs is a fools errand. Gross Margins are getting crushed, and prescription growth cannot make up the difference. Our company will NEVER make a profit big enough to pay off the $300M debt. See below:

Needham & Company
downgraded Pernix Therapeutics (NASDAQ: PTX) from Buy to Hold.

Analyst Serge Belanger commented, "Late-2015 softness led to a 4Q15 miss and initial 2016 guidance points to continued challenges to growth prospects and the ongoing turnaround strategy. While Zohydro shows signs of promise, both Silenor and Treximet are likely to run in place as increasing Rx volume growth will be required to offset negative gross-to-net adjustments. The limited growth will restrict PTX's ability to delever (current net debt: ~$299) and implement initiatives to re-acclerate growth. We expect PTX to take up residency in the "penalty box" until there are signs of higher sustainable growth and/or an outcome from ongoing strategic alternative explorations."

 

[anonymous]

Signing bad managed care contracts just to gain access at all costs is a fools errand. Gross Margins are getting crushed, and prescription growth cannot make up the difference. Our company will NEVER make a profit big enough to pay off the $300M debt. See below:

Needham & Company
downgraded Pernix Therapeutics (NASDAQ: PTX) from Buy to Hold.

Analyst Serge Belanger commented, "Late-2015 softness led to a 4Q15 miss and initial 2016 guidance points to continued challenges to growth prospects and the ongoing turnaround strategy. While Zohydro shows signs of promise, both Silenor and Treximet are likely to run in place as increasing Rx volume growth will be required to offset negative gross-to-net adjustments. The limited growth will restrict PTX's ability to delever (current net debt: ~$299) and implement initiatives to re-acclerate growth. We expect PTX to take up residency in the "penalty box" until there are signs of higher sustainable growth and/or an outcome from ongoing strategic alternative explorations."

The later is more likely... Sold before year end bet on it

 

[anonymous]

Signing bad managed care contracts just to gain access at all costs is a fools errand. Gross Margins are getting crushed, and prescription growth cannot make up the difference. Our company will NEVER make a profit big enough to pay off the $300M debt. See below:

Needham & Company
downgraded Pernix Therapeutics (NASDAQ: PTX) from Buy to Hold.

Analyst Serge Belanger commented, "Late-2015 softness led to a 4Q15 miss and initial 2016 guidance points to continued challenges to growth prospects and the ongoing turnaround strategy. While Zohydro shows signs of promise, both Silenor and Treximet are likely to run in place as increasing Rx volume growth will be required to offset negative gross-to-net adjustments. The limited growth will restrict PTX's ability to delever (current net debt: ~$299) and implement initiatives to re-acclerate growth. We expect PTX to take up residency in the "penalty box" until there are signs of higher sustainable growth and/or an outcome from ongoing strategic alternative explorations."

Obviously you didn't read Dougs email today. It's your fault for not selling enough you loser

 

[anonymous]

Obviously you didn't read Dougs email today. It's your fault for not selling enough you loser

Doug can say whatever, its his fault. The margins are not down because of managed care, that is nonsensical. The margins are crushed because DD, RS etc believe a dream that PPD would be the savior for Trex and Sile. They jacked up Treximet to an unsustainable price hoping Pernix could be another Valeant or Horizon. I know for a fact that was the whisper in house. Everyone else is doing it why dont we? Now that PBM are on to the scheme, there is no coverage, so we fill every fill with 0, I mean 0 reimbursement. Once again a dollar and a day late. Dont blame us dougy, look in the mirror.

 

[anonymous]

Falling bad again today. Looks like the cats outta the bag. Dust off the resumes now